Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chaishi Tuire granules
- Development stage
- Phase 4
- Lead developer
- Sinopharm
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Chaishi Tuire granules (CSTRG) is a traditional Chinese patent medicine widely used in China for the treatment of respiratory infections, particularly influenza. It is a multi-herb formulation composed of ten traditional Chinese medicinal herbs, including *Lonicera japonica* Thunb, *Rheum officinale*, *Bupleuri Radix*, *Isatis indigotica*, *Forsythia suspensa*, *Artemisia annua*, *Anemarrhena asphodeloides*, *Taraxacum* (Dandelion), *Scutellaria baicalensis*, and Gypsum Fibrosum. CSTRG exerts its therapeutic effects primarily through anti-inflammatory and immunomodulatory mechanisms, specifically by inhibiting the expression of pro-inflammatory cytokines such as TNF-alpha and IL-6 via the modulation of the TRAF6/MAPK14 signaling pathway. It is clinically evaluated in Phase 4 trials for the treatment of adult influenza, demonstrating efficacy in fever resolution and symptom improvement comparable to oseltamivir.
- Brand names
- Chaishi Tuire Granules
- Other names
- Chai Shi Tui Re Ke LiChaishi Tuire granuleCSTRG柴石退热颗粒
02
Targets
IL-6 (Interleukin 6)TRAF6MAPK14 (p38 mitogen-activated protein kinase alpha)
Beyond the preview
Go deeper on Chaishi Tuire granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chaishi Tuire granules.